Integrative Physiology |
From Cardiovascular Medicine (T.I., H.T., S.K., N.S., S.H., Y.M., K.E., A.T.), Graduate School of Medical Sciences, and Department of Biophysics, Faculty of Pharmaceutical Sciences (K.I., H.U.), Kyushu University, Fukuoka, Japan.
Correspondence to Hiroyuki Tsutsui, Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. E-mail prehiro{at}cardiol.med.kyushu-u.ac.jp
| Abstract |
|---|
|
|
|---|
Key Words: antioxidant free radicals heart failure myocardial contraction myocardium
| Introduction |
|---|
|
|
|---|
,
major biochemical consequences of reactive oxygen species (ROS)
generation have been found to be elevated in plasma1 and
pericardial fluid,2 respectively. Animal studies have
shown that antioxidant enzyme activities are decreased and TBARS are
increased in HF myocardium.3 4 5 Even though
these studies suggest that ROS are increased in the failing heart, all
findings are inconclusive and a direct measurement of ROS has not been
performed. Further, it remains unknown which species among 3 major
oxygen metabolites, superoxide anion
(·O2-), hydrogen
peroxide (H2O2), and
hydroxyradical (·OH), are responsible for oxidative stress in
HF. We have recently demonstrated that ·O2- production is increased in the submitochondrial particle fractions isolated from canine failing hearts as a result of rapid ventricular pacing.6 We measured ·O2- by using electron spin resonance (ESR) spectroscopy with 5,5'-dimethyl-1-pyrroline-N-oxide (DMPO) as a spin trap, a standard method to detect ROS in the biological tissue. Even though it can quantify ·O2- with high sensitivity and specificity, DMPO adducts are unstable and fall below the detection limits when measured in the multicellular tissue, and thus the fractionation of subcellular components should be required to obtain measurable ESR signals.6 When the subcellular fractions are used, the effects of scavenging enzymes such as superoxide dismutase (SOD), glutathione peroxidase, and catalase, as well as nonenzymatic antioxidants in the cytoplasm, are ignored. Further, because of high specificity of DMPO for ·O2-, DMPO is not applicable for assessing the concomitant formation of other ROS such as H2O2 and ·OH within the tissue. Therefore, it still remains unanswered whether the production of downstream ROS is indeed enhanced in the failing myocardium.
Recent studies have shown that the formation of ROS can be monitored by using ESR combined with the nitroxide radical 4-hydroxy-2,2,6,6-tetramethyl-piperidine-N-oxyl (hydroxy-TEMPO) as a spin probe.7 8 9 Nitroxide radical is a stable chemical and thus can be easily detected by ESR. Biological reductants can reduce nitroxides into corresponding nonparamagnetic hydroxylamine compounds, which are ESR silent.7 8 Therefore, the reduction of nitroxides into nonparamagnetic products can provide a new dimension in monitoring redox metabolism within the biological tissue.10 11 12
The present study aimed to address the question whether ·OH production is increased in the HF myocardium. For this purpose, we measured the rate of hydroxy-TEMPO ESR signal decay in the presence of myocardial tissue and compared its rate between control and HF. To delineate the origin of ·OH generated in HF, the effects of ROS scavengers and iron chelator on ·OH production were examined.
| Materials and Methods |
|---|
|
|
|---|
In Vitro Validation Studies
To interpret the rate of ESR signal decay accurately and to
confirm its efficiency in the quantification of ROS, we performed in
vitro validation studies on the metabolism of hydroxy-TEMPO
in the presence of the exogenous ROS generating system before applying
this method to the failing heart. ·OH was generated in vitro by
the combination of H2O2 (1
to 5 mmol/L) plus Fe3+-nitriotriacetate
(NTA; 20 µmol/L), and
·O2- was generated in
vitro by xanthine (500 µmol/L) plus xanthine oxidase (20 mU/mL).
All ESR samples were prepared using PBS (150 mol/L NaCl, 3 mmol/L
KCl, and 5 mmol/L phosphate; pH 7.4), mixed quickly, and then
drawn into glass tubes. The reaction mixture was immediately reacted
with hydroxy-TEMPO (0.1 mmol/L) in PBS, and its ESR spectra were
recorded for up to 10 minutes at intervals of 10 to 15 seconds. The
rate of signal decay was measured in the presence of exogenous
·OH or ·O2-.
Animal Model of HF
HF was produced in adult mongrel dogs by rapid
ventricular pacing according to methods described
previously.6 All procedures and animal care were approved
by the Committee on Ethics of Animal Experiments, Kyushu University,
and conducted according to animal care guidelines of the American
Physiological Society.
Quantification of ROS in Myocardial Tissue
At the time of the study, the animals were euthanized by a
lethal dose of pentobarbital. Freeze-clamped left
ventricular (LV) myocardial samples were
homogenized in 50 mmol/L sodium phosphate buffer (pH
7.4) containing protease inhibitors. The
homogenate was immediately reacted with hydroxy-TEMPO
(0.1 mmol/L), and its ESR spectra were recorded as described
above. The formation of ·OH was confirmed by adding
dimethylthiourea (DMTU; 50 mmol/L) into the
reaction mixture. The contribution of
·O2- and
H2O2 was examined in the
presence of 4,5-dihydroxy-1,3-benzene disulfonic acid (Tiron; LaMotte)
(100 µmol/L) and catalase (50 U/mL) as a competitive reagent,
respectively.
Statistical Analysis
Data are expressed as mean±SEM. To compare the data between
control and HF, a Student unpaired t test was used. For
multiple comparisons, 1-way ANOVA was used to evaluate mean differences
in conjunction with a post hoc test with the Scheffé correction.
Correlation was examined by linear regression analysis using
the least square method. Multiple regression analysis was also
performed to analyze the relation between the signal decay and
LV contractile function. All tests were considered statistically
significant at P<0.05.
An expanded Materials and Methods section is available online at http://www.circresaha.org.
| Results |
|---|
|
|
|---|
|
|
Animal Characteristics
Chronic rapid ventricular pacing caused an
89%
increase in end-systolic LV dimension and a 51% decrease in LV
ejection fraction by echocardiography. For the HF
dogs, LV peak positive dP/dt was depressed, and LV
end-diastolic pressure was increased, compared with control
values (Table
).
|
ROS Production in HF Myocardium
To determine whether ·OH production is enhanced in
the failing myocardium, myocardial tissue
homogenates were reacted with hydroxy-TEMPO, and its ESR
spectra were recorded. The intensity of ESR signals reduced more
rapidly in HF hearts compared with control (Figure 3A
). There was also a linear relation in
the semilogarithmic plot of peak signal intensity versus time (Figure 3B
). The rate of signal decay, calculated from the slope of this
line, was significantly (P<0.01) higher in HF (0.047±0.002
versus 0.024±0.002 minutes; Figure 3C
). In the absence of
myocardial tissue, ESR signals did not decline during the time of
study. DMTU (50 mmol/L) abolished the increase in the rate of
signal decay seen in HF (Figure 3C
), confirming an enhanced
generation of ·OH.
|
Desferrioxamine (0.5 mmol/L), an iron chelator, also inhibited the
increase of signal decay in HF (Figure 3C
), indicating that the
highly reactive ·OH radical is generated via interaction of
·O2- and
H2O2 through the
iron-catalyzed Harber-Weiss reaction
(·O2-+H2O2
·OH+OH-+·O2-)
and/or interaction of H2O2
and iron through the Fenton reaction
(H2O2+Fe2+
·OH+OH-+Fe3+).
Catalase (50 U/mL) also attenuated the increased rate of signal decay
in HF (Figure 3C
), which implies the existence of a component of
H2O2 in the
production of ·OH. Further, Tiron, a nonenzymatic
·O2- scavenger, and
catalase were similarly effective in attenuating the increase of the
signal decay (Figure 3C
), which suggested that
·O2- contributed to the
production of H2O2.
Importantly, for control, catalase (50 U/mL) and DMTU (50 mmol/L)
had no such effects on the rate of signal decay. Taken together,
·O2- is primarily
produced in the failing heart and is converted into
H2O2 and further to
·OH via iron-catalyzed reaction.
ROS Production Under Functional Block of Mitochondria in
Normal Myocardium
To further confirm that
H2O2 and ·OH can be
secondarily produced when
·O2- is present
within the myocardium, ROS production was assessed
in the presence of antimycin A (200 µmol/L). Antimycin A has
been shown to selectively block the mitochondrial electron transport at
the site of complex III and to enhance the production of
·O2-.6 ESR
signals of hydroxy-TEMPO in the presence of normal myocardial
homogenates were also observed as 3 sharp lines (Figure 4A
). At baseline conditions, the peak
signal intensity decreased slowly with time. In the presence of
antimycin A (200 µmol/L), ESR signal decay was significantly
accelerated (Figure 4A
and 4B
). Similarly to HF hearts, this
increase was inhibited by DMTU (100 mmol/mL), desferrioxamine
(0.5 mmol/L), and catalase (100 U/mL), indicating that
endogenously generated
·O2- is converted to
H2O2 and further to
·OH in the myocardial tissue. These results further demonstrate
that the formation of
·O2- can mimic the
production of downstream ROS seen in HF.
|
Relation Between ROS and Contractile Dysfunction
To determine whether the myocardial level of ROS is correlated to
the severity of HF, LV contractile function indices were plotted
against the rate of signal decay measured using the same hearts. This
analysis was possible because myocyte contractile function
varied widely within a group of HF animals. There was a significant
inverse relation between the rate of signal decay and LV ejection
fraction (r=0.869, n=19 dogs; P<0.01; Figure 5A
) and positive correlation between the
rate of decay and LV end-diastolic pressure
(r=0.901, n=18 dogs; P<0.01; Figure 5B
).
A significant correlation was also found even in the analysis
of the HF group only (r=0.684, n=10 dogs, P<0.01
for LV ejection fraction, and r=0.724, n=9 dogs,
P<0.01 for LV end-diastolic pressure).
|
A multiple linear regression analysis was performed to analyze the relation between the rate of signal decay, LV ejection fraction, and LV end-diastolic pressure. There was a significant positive correlation between the rate of signal decay and LV end-diastolic pressure (P<0.05), but not with ejection fraction. Further, there was a significant inverse relation between LV ejection fraction and LV end-diastolic pressure (P<0.05).
| Discussion |
|---|
|
|
|---|
Measurement of ROS by ESR
It is difficult to quantify the amount of ROS in the intact
biological system, because they are unstable and rapidly react with
unoxidized adjacent molecules, and thus their half-life is very short.
ESR combined with a spin trap such as DMPO is a reliable, direct method
for measuring ROS.13 14 However, the application of this
method to the biological sample is limited because of the low stability
of DMPO adducts within the tissue. We thus used ESR spectroscopy with
hydroxy-TEMPO in the present study to quantify ROS. Nitroxide
radical is a stable chemical and can be easily detected by
ESR.7 8 9 Biological reductants can reduce nitroxides into
corresponding nonparamagnetic hydroxylamine compounds, which are ESR
silent.7 Therefore, the decay of nitroxides can provide a
direct method to assess the generation of ROS within biological tissues
in vitro,15 as well as in vivo.10 12 This
method provides several advantages in the assessment of ROS generation.
First, it can allow a direct quantitative assessment of ROS, which is
not possible with other techniques to measure byproducts of ROS
such as TBARS and 8-iso-PGF2
. Our in vitro validation studies have
confirmed that the increase in the rate of signal decay is proportional
to the amount of ·OH. Second, this method does not require
complicated procedures to prepare the subcellular fractions, which may
alter the status of ROS. It can measure the net amount of ROS in the
presence of antioxidants and/or reductants within the whole tissue.
Therefore, this method is considered to reproduce the in vivo setting
more closely than other techniques.
We have to acknowledge 2 crucial limitations of ESR measurement with
nitroxide radical. First, given the highly transient nature of ROS, ESR
measurement procedures themselves may modify the status of ROS by
destroying antioxidant defenses and/or activating the oxidant
production system. However, the contribution of artifactual
generation of ROS in our measurement is considered to be minimal, given
that the rate of signal decay was not altered by ROS scavengers in
normal myocardium. Second, the reduction of hydroxy-TEMPO
might not be specific for ROS in living tissue, because
hydroxy-TEMPO can lose its paramagnetism not only by direct
interaction with ·OH but also by various mechanisms, including
the reductants in the cytosol, 1-electron reduction due to enzymatic
processes, and mitochondrial electron flow.11 However, the
contribution of other mechanisms in the reduction of hydroxy-TEMPO
could be neglected in our quantification, because we confirmed that
increased rate of signal decay in HF was inhibited in the presence of
specific ·OH scavenger within the reaction mixture (Figure 3
).
Oxidative Stress in HF
The present study has provided a definitive and direct
demonstration of enhanced generation of ROS in the failing
myocardium. These results are concordant with our recent
study using the subcellular fractions that
·O2- production
was increased in HF mitochondria.6 They are also in
agreement with the studies by others in which TBARS and 8-iso-PGF2
are increased in HF.1 2
·O2- is a primary
radical that can lead to the formation of other ROS, such as
H2O2 and ·OH. The
present study has demonstrated that
·O2- leads to the
formation of H2O2 and
·OH in the failing myocardium (Figures 3
and 4
). ·OH arises from electron exchange between
·O2- and
H2O2 via the Harber-Weiss
reaction. In addition, ·OH is also generated by the reduction of
H2O2 in the presence of
endogenous iron by means of the Fenton reaction. The
generation of ·OH implies a
pathophysiological significance of ROS in HF, given
that ·OH radicals have been suggested to be the predominant
oxidant species causing cellular injury.16
The present study has demonstrated that
·O2- produced in the
presence of antimycin A can lead to the further generation of
downstream ROS, including
H2O2 and ·OH, within
the myocardium (Figure 4
). Our recent study
indicated that ·O2-
production was enhanced in the mitochondria from the failing
heart.6 Taken together, it is conceivable that
·O2- originated from the
mitochondrial complex I could lead to the production of
H2O2 and ·OH in
HF.
Previous studies by Haywood et al17 and by us18 have demonstrated enhanced production of NO in the failing heart, which originated from inducible NO synthase. ·O2- and NO can react to the powerful prooxidant, peroxynitrite, which can form hydroxyl radicals. Peroxynitrite can increase the rate of hydroxy-TEMPO signal decay and might be involved in the development of HF.
Both ·OH and ·O2-
can diminish myocardial contractile function19 and also
cause lipid peroxidation of membrane phospholipids, which ultimately
leads to myocyte structural damage.20 Recently, ROS have
been suggested to be involved in apoptosis,21 22
which might play an important role in the pathogenesis of HF. Moreover,
ROS can cause endothelial dysfunction23
and induce arrhythmia, both of which may contribute to the
progression of HF. Therefore, oxidant stress may play an important role
in myocardial failure. This is supported by a close correlation between
oxidative stress and contractile dysfunction in this study (Figure 5
). Nonetheless, we have to admit that our findings do not prove
a causal relation. Indeed, given the importance of ROS in the
pathophysiology of HF, it is crucial to determine the effects of
radical scavengers on the reversibility or prevention of HF, and an
establishment of a cause-and-effect relationship is a major focus of
our future research. In our preliminary studies using a mouse model of
myocardial infarction and failure, chronic
intraperitoneal administration of DMTU (50 mg/kg
per day) could attenuate the production of ·OH in the
myocardium and also LV remodeling process (cavity
dilatation), as well as contractile failure without affecting the size
of myocardial infarction (our unpublished data, 1999). These
results may suggest that oxidative stress could be an important cause
in the initiation and progression of HF.
Conclusions
The present study provided definite and direct evidence for an
increased production of ·OH originating from
·O2- and
H2O2 in the failing
myocardium. Oxidative stress was in parallel to LV
contractile dysfunction. The enhanced production of ROS might
play an important role in the pathogenesis of HF.
| Acknowledgments |
|---|
Received September 16, 1999; accepted November 3, 1999.
| References |
|---|
|
|
|---|
in pericardial fluid of patients with heart failure: a potential role
for in vivo oxidant stress in ventricular dilatation
progression to heart failure. Circulation. 1998;97:15361539.This article has been cited by other articles:
![]() |
T. Tsutsumi, T. Ide, M. Yamato, W. Kudou, M. Andou, Y. Hirooka, H. Utsumi, H. Tsutsui, and K. Sunagawa Modulation of the myocardial redox state by vagal nerve stimulation after experimental myocardial infarction Cardiovasc Res, March 1, 2008; 77(4): 713 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Vecoli and N. Paolocci When the heart sleeps... Is the vagus resetting the myocardial 'redox clock'? Cardiovasc Res, March 1, 2008; 77(4): 609 - 611. [Full Text] [PDF] |
||||
![]() |
C. Ricci, V. Pastukh, J. Leonard, J. Turrens, G. Wilson, D. Schaffer, and S. W. Schaffer Mitochondrial DNA damage triggers mitochondrial-superoxide generation and apoptosis Am J Physiol Cell Physiol, February 1, 2008; 294(2): C413 - C422. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Shang, S. Sanyal, A. E. Pfahnl, Z. Jiao, J. Allen, H. Liu, and S. C. Dudley Jr. NF-{kappa}B-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin II Am J Physiol Cell Physiol, January 1, 2008; 294(1): C372 - C379. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Zhang, X. Xu, X. Hu, E. D. van Deel, G. Zhu, and Y. Chen Inducible Nitric Oxide Synthase Deficiency Protects the Heart From Systolic Overload-Induced Ventricular Hypertrophy and Congestive Heart Failure Circ. Res., April 13, 2007; 100(7): 1089 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Doerries, K. Grote, D. Hilfiker-Kleiner, M. Luchtefeld, A. Schaefer, S. M. Holland, S. Sorrentino, C. Manes, B. Schieffer, H. Drexler, et al. Critical Role of the NAD(P)H Oxidase Subunit p47phox for Left Ventricular Remodeling/Dysfunction and Survival After Myocardial Infarction Circ. Res., March 30, 2007; 100(6): 894 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Madamanchi and M. S. Runge Mitochondrial Dysfunction in Atherosclerosis Circ. Res., March 2, 2007; 100(4): 460 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Berndt, C. H. Lillig, and A. Holmgren Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1227 - H1236. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nojiri, T. Shimizu, M. Funakoshi, O. Yamaguchi, H. Zhou, S. Kawakami, Y. Ohta, M. Sami, T. Tachibana, H. Ishikawa, et al. Oxidative Stress Causes Heart Failure with Impaired Mitochondrial Respiration J. Biol. Chem., November 3, 2006; 281(44): 33789 - 33801. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Matsushima, S. Kinugawa, T. Ide, H. Matsusaka, N. Inoue, Y. Ohta, T. Yokota, K. Sunagawa, and H. Tsutsui Overexpression of glutathione peroxidase attenuates myocardial remodeling and preserves diastolic function in diabetic heart Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2237 - H2245. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Zimmet and J. M. Hare Nitroso-Redox Interactions in the Cardiovascular System Circulation, October 3, 2006; 114(14): 1531 - 1544. [Full Text] [PDF] |
||||
![]() |
A. Laskowski, O. L. Woodman, A. H. Cao, G. R. Drummond, T. Marshall, D. M. Kaye, and R. H. Ritchie Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes Cardiovasc Res, October 1, 2006; 72(1): 112 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Hingtgen, X. Tian, J. Yang, S. M. Dunlay, A. S. Peek, Y. Wu, R. V. Sharma, J. F. Engelhardt, and R. L. Davisson Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy Physiol Genomics, September 14, 2006; 26(3): 180 - 191. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Murdoch, M. Zhang, A. C. Cave, and A. M. Shah NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure Cardiovasc Res, July 15, 2006; 71(2): 208 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Song, J. C. Shryock, S. Wagner, L. S. Maier, and L. Belardinelli Blocking Late Sodium Current Reduces Hydrogen Peroxide-Induced Arrhythmogenic Activity and Contractile Dysfunction J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 214 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Matsushima, T. Ide, M. Yamato, H. Matsusaka, F. Hattori, M. Ikeuchi, T. Kubota, K. Sunagawa, Y. Hasegawa, T. Kurihara, et al. Overexpression of Mitochondrial Peroxiredoxin-3 Prevents Left Ventricular Remodeling and Failure After Myocardial Infarction in Mice Circulation, April 11, 2006; 113(14): 1779 - 1786. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-s. Liang, W. Mao, C. Iwai, S. Fukuoka, and S. Y. Stevens Cardiac sympathetic neuroprotective effect of desipramine in tachycardia-induced cardiomyopathy Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H995 - H1003. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ichihara, A. Noda, K. Nagata, K. Obata, J. Xu, G. Ichihara, S. Oikawa, S. Kawanishi, Y. Yamada, and M. Yokota Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failure Cardiovasc Res, February 15, 2006; 69(3): 726 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Hajjar and J. A. Leopold Xanthine Oxidase Inhibition and Heart Failure: Novel Therapeutic Strategy for Ventricular Dysfunction? Circ. Res., February 3, 2006; 98(2): 169 - 171. [Full Text] [PDF] |
||||
![]() |
M. Nimata, T.-a. Okabe, M. Hattori, Z. Yuan, K. Shioji, and C. Kishimoto MCI-186 (edaravone), a novel free radical scavenger, protects against acute autoimmune myocarditis in rats Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2514 - H2518. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Cucoranu, R. Clempus, A. Dikalova, P. J. Phelan, S. Ariyan, S. Dikalov, and D. Sorescu NAD(P)H Oxidase 4 Mediates Transforming Growth Factor-{beta}1-Induced Differentiation of Cardiac Fibroblasts Into Myofibroblasts Circ. Res., October 28, 2005; 97(9): 900 - 907. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ikeuchi, H. Tsutsui, T. Shiomi, H. Matsusaka, S. Matsushima, J. Wen, T. Kubota, and A. Takeshita Inhibition of TGF-{beta} signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction Cardiovasc Res, December 1, 2004; 64(3): 526 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Tomaselli and D. P. Zipes What Causes Sudden Death in Heart Failure? Circ. Res., October 15, 2004; 95(8): 754 - 763. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Han, H. Long, H. Wang, J. Wang, Y. Zhang, and Z. Wang Progressive apoptotic cell death triggered by transient oxidative insult in H9c2 rat ventricular cells: a novel pattern of apoptosis and the mechanisms Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2169 - H2182. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kishi, Y. Hirooka, Y. Kimura, K. Ito, H. Shimokawa, and A. Takeshita Increased Reactive Oxygen Species in Rostral Ventrolateral Medulla Contribute to Neural Mechanisms of Hypertension in Stroke-Prone Spontaneously Hypertensive Rats C |